Beroni Group

Using Modern Science and Technology to Improve Human Health

cell therapies

Immune Cell Therapy

Focus on immune cell therapy including gene detection and diagnosis, immunotherapy for cancer treatment.


R&D of New Drugs and Clinical Trial

Develop new anti-cancer drugs and actively seeking new collaboration opportunities.


Diagnosis of Infectious Diseases

Develop diagnostic tools for detecting infectious diseases.



Develop a strong e-commerce platform for sales of pharmaceutical,healthcare and cosmetic products.

World's Leading Enterprise in

Beroni Group is an international biotechnological company listed on the National Stock Exchange (Australia) and traded on the OTC markets in the USA, with business presence in Australia, China, Japan and the USA. It currently has four core businesses – research and development of new drugs and clinical trial, immune cell therapy including gene detection and diagnosis, immunotherapy for cancer treatment, diagnosis of infectious diseases and e-commerce based on the Internet sales of pharmaceutical, healthcare and cosmetic products.

Beroni Group’s overall strategic goal is to become a world’s leading enterprise in the biotechnology, life sciences, and environmental science industries.


Countries in operation


Research scientists


Award nominations


product types

Beroni Australia

Suite 401, 447 Kent Street,
Sydney, NSW 2000

  • +61 2 8051 3055

Beroni China

Level 10/ Building 11
Zhong Bei High Technology Industry Park
XiQing District, Tianjin

  • +86 22 5995 5753

Beroni Japan

1 – 144#6 Ginza, Tyuo-ku
Tokyo 104-0061

  • +81 3 3863 8998

Dendrix Inc.

4F, Closepoint Building
3-29-1, Ebisu
Shibya-ku, Tokyo

  • +81 3 5475 6411

Medicine Plus

8F, Chiyoda Building East
2-9-4 Higashi Tenman Kita-ku
Osaka-shi, Osaka

  • +81 6 6358 8151

Beroni USA

2083 Center Avenue #3A
Fort Lee
New Jersey 07024
United State of America

  • +1 214 762 2888
Close Menu